Tetsuomi Takano President, CEO and Principal Consultant
〜 Tetsuomi Takano’s Biography 〜
March 1986
Graduated from Tokyo University of Science, Faculty of Pharmaceutical Sciences
April 1986
Joined Astellas Pharma Inc. (formerly Yamanouchi Pharmaceutical Co., Ltd. till March 2005) and assigned to the Sales & Marketing division
October 1992
Moved to the Clinical Development division, Astellas Pharma Inc.
October 2002
Clinical Research Manager, Clinical Development, Astellas Pharma Inc.
June 2003
Senior Manager, Asian Clinical Development, Astellas Pharma Inc.
April 2006～March 2016
Senior Director, Head of Asian Development Strategy, Astellas Pharma Inc.
April 2016～March 2017
Senior Director, External Relations, Astellas Pharma Inc.
May 2017～September 2023
Senior Strategy Director, Strategy & Planning, Covance Inc. (Engaged in providing clients with strategies and solutions for clinical development, primarily IND/NDA and clinical trials for pharmaceutical products, with a focus on Japan and Asia)
October 2023
Founded t2T Healthcare Inc. and became President and CEO
〜 Tetsuomi Takano’s Activities in the Industry 〜
October 2008～Present
Cofounded a voluntary study group for Asian development strategies and regulatory intelligence in the pharmaceutical industry “Red Dragon Conference” and became the Vice-Chairperson (Promoted to the Chairperson in 2014)
January 2013～April 2016
Advisor, Asia Committee, International Affairs Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
April 2016～March 2017
Vice-Chairperson and Head of Development, Asia Committee, International Affairs Committee, JPMA
August 2016～January 2021
PProgram Committee Member, Moderator and Speaker for APEC Center of Excellence Workshop “PMDA-Asia Training Center Multi-Regional Clinical Trials (MRCT) Seminar”
September 2020～Present
PMDA’s China Expert Committee Member with MHLW, the Embassy of Japan in China, National Cancer Center, and key Industry Associations
July 2021～Present
Co-Founder, Editor-in-Chief and Primary Writer for Web Magazine of “Drug R&D Expert”
2007～Present
More than 50 times of lecture presentations in academic conferences in Tokyo, Beijing, Shanghai, Suzhou, Taipei, Seoul, Busan, Singapore, and the U.S., etc.
